Format

Send to

Choose Destination
See comment in PubMed Commons below
Ophthal Plast Reconstr Surg. 2011 May-Jun;27(3):190-4. doi: 10.1097/IOP.0b013e318201d344.

Propranolol for the treatment of orbital infantile hemangiomas.

Author information

1
Department of Ophthalmology, University of South Florida College of Medicine, Tampa, Florida, USA.

Abstract

PURPOSE:

To evaluate the treatment of orbital infantile hemangiomas with systemic (oral) propranolol.

METHODS:

This study was a retrospective observational case series of 5 infants who were diagnosed with orbital infantile hemangiomas between March and July of 2009.

RESULTS:

The average age at presentation was 3.1 months (3 weeks to 9 months). The patients received oral propranolol, with dosage varying among study centers. The patients were treated for an average of 7.1 months. Treatment of 5 infantile hemangioma patients with oral propranolol produced a significant reduction in the size of the hemangioma in 4 (80%) of the patients and a minimal improvement in one patient. No patient had significant adverse events during the treatment period.

CONCLUSION:

Oral propranolol may be an effective treatment for orbital infantile hemangiomas.

Comment in

PMID:
21283032
DOI:
10.1097/IOP.0b013e318201d344
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Support Center